HGH fragment 176-191 dosage in research typically runs 250-500 mcg daily, often split into two doses. Learn timing, stacking, and reported side effects.
Most research protocols for the peptide list an HGH fragment 176-191 dosage of 250 to 500 mcg per day, injected subcutaneously and often split into two separate doses. That range comes from animal studies and early-stage research rather than large human trials, so no official dosing standard exists. HGH fragment 176-191 is not FDA-approved for human use in the United States.
What HGH Fragment 176-191 Is
HGH fragment 176-191 is a synthetic peptide that mirrors the last 16 amino acids of the human growth hormone chain. Researchers study it primarily for fat metabolism, since it appears to drive lipolysis without the broad growth and blood-sugar effects of full growth hormone.
Unlike full growth hormone, HGH fragment 176-191 does not meaningfully raise IGF-1 levels or stimulate systemic growth. Discussions of hgh fragment 176 191 benefits therefore center on body-fat reduction rather than muscle gain.
Some suppliers attach a tyrosine molecule to the fragment to create AOD-9604, a related peptide with its own research history and dosing conventions.
Standard HGH Fragment 176-191 Dosage Ranges
Nearly every protocol circulating in research forums lands inside the same window. Doses are measured in micrograms (mcg), and most vials hold 2 mg or 5 mg of lyophilized powder.
| Research dose level | Daily amount | Frequency | Notes |
|---|---|---|---|
| Low | 200-250 mcg | Once daily | Often used for a first research run |
| Standard | 250-500 mcg | Once or twice daily | Most commonly cited range |
| High | 500-1,000 mcg | Split into two doses | No controlled human data shows added benefit |
A 5 mg vial reconstituted with 2 mL of bacteriostatic water yields about 2,500 mcg per mL, so a U-100 insulin syringe delivers roughly 25 mcg per unit. That makes the 250 mcg and 500 mcg marks easy to draw accurately.
Charts labeled hgh frag 176 191 dosage sometimes push toward 1,000 mcg per day. Higher amounts mainly increase the odds of injection-site irritation, and no controlled trial has shown better fat-loss results above 500 mcg.
Injection Timing, Frequency, and the Fasting Question
HGH fragment 176-191 has a short half-life of roughly 30 minutes, so many protocols split the daily dose into two injections.
Common timing templates include:
- Morning, right after waking and before the first meal
- Pre-workout, at least 30 minutes after the last food
- Before bed, at least two hours after dinner
Fasting is emphasized because insulin and circulating free fatty acids can blunt the peptide's lipolytic signaling in research models. Most protocols call for a 30-to-60-minute buffer on either side of an injection.
Whether a protocol is written as hgh frag 176-191 dosage or spelled out in full, the fasting and injection-timing logic stays the same.
How HGH Fragment 176-191 Compares With Other Compounds
Readers often search hgh fragment 176-191 vs aod 9604 to find out whether the two fat-loss peptides can be swapped one for one. They cannot, because the molecules differ slightly and their research doses are set independently.
| Compound | Main research focus | Typical research dose | IGF-1 impact |
|---|---|---|---|
| HGH fragment 176-191 | Fat metabolism | 250-500 mcg per day | Minimal |
| AOD-9604 | Fat metabolism | 300-600 mcg per day | Minimal |
| Somatropin (full hGH) | Growth and body composition | 1-4 IU per day (clinical) | Significant increase |
AOD-9604 is a related but distinct peptide, so dosing information for one does not automatically apply to the other.
The gap with full growth hormone is wider. Anyone weighing hgh fragment 176-191 vs somatropin should note that somatropin raises IGF-1 and affects growth, glucose, and fluid retention, while the fragment has minimal IGF-1 impact.
Some suppliers sell a fragment 176-191 & cjc-1295 & ipamorelin blend, which complicates dosing because each ingredient has its own target amount. Splitting a blend dose across three compounds usually means each one lands below its standalone research range.
Reported Side Effects and Safety Considerations
Most hgh fragment 176 191 side effects described in user reports are mild: redness, itching, or a small lump at the injection site, occasional headache, and short-lived fatigue. Because controlled human safety data is limited, long-term risks remain unknown.
HGH fragment 176-191 is sold as a research chemical, not a medication, and purity varies widely between suppliers. Anyone considering it should review the risks with a healthcare professional and avoid combining it with prescription drugs without medical guidance.
Reconstitution, Storage, and Cycle Length
Reconstitute the lyophilized powder with bacteriostatic water, swirl gently, and never shake the vial. Store unmixed powder in the freezer and reconstituted peptide in the refrigerator, protected from light.
Typical research cycles run 4 to 12 weeks, followed by a break. There is no established human dosing schedule, so cycle length is a research convention rather than a clinical recommendation.
Frequently Asked Questions
What is the standard HGH fragment 176-191 dosage per day?
Most research protocols use 250 to 500 mcg per day, injected subcutaneously once or twice. Smaller amounts of 200-250 mcg are common for a first research run, and doses above 500 mcg have no controlled human data supporting better results. HGH fragment 176-191 is a research chemical, not an FDA-approved medication.
Should HGH fragment 176-191 be injected on an empty stomach?
Most protocols recommend a fasted state, usually 30 to 60 minutes away from food. Insulin and circulating free fatty acids can interfere with the peptide's lipolytic signaling in research models. Morning and pre-workout injections are the most common timing choices.
How long do people run HGH fragment 176-191?
Research cycles usually last 4 to 12 weeks, often followed by a break. No clinical trial has established a safe or effective human cycle length for this peptide. Anyone considering use should discuss it with a healthcare professional first.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.